4.8 Article

Autophagy Insights from DEspR-deficiency and haploinsufficiency

Journal

AUTOPHAGY
Volume 5, Issue 2, Pages 259-262

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/auto.5.2.7617

Keywords

autophagy; neural development; neurodegeneration; spongiform changes; DEspR

Categories

Funding

  1. NIH [HL086532]

Ask authors/readers for more resources

We recently showed that DEspR-haploinsufficiency resulted in increased neuronal autophagy and spongiform changes in the adult brain especially the hippocampus, cerebral cortex and basal ganglia, causing cognitive performance deficits. This model demonstrates a causal link between increased autophagy and neurodegenerative changes. This is in contrast with recent observations that decreased autophagy from null mutations of autophagy genes, Atg5 and Atg7, results in early neurodegenerative changes. With the observed autophagy phenotype, we then compared the neural tube phenotype of DEspR-deficient mice with knockout mice of genes established to underlie or regulate autophagy. Intriguingly, the hyperproliferative neuroepithelium observed in DEspR-deficient embryos is also detected in null mutants of Ambra1, an autophagy modulator, and two apoptosis genes, Apaf1 and Caspase 9. While all four knockout models exhibited hyperproliferative neuroepithelium, DEspR-deficient mice differed by having greater neural tube cavitation. Additionally, observed DEspR roles in angiogenesis and autophagy recapitulated the association of angiogenesis inhibition and increased autophagy as observed for endostatin and kringle5, thus elucidating an expanding complex network of autophagy, apoptosis and angiogenesis in neuroepithelial development, and an emerging complex spectrum of autophagy effects on neurodegeneration. Nevertheless, DEspR provides a ligand-activated receptor system to modulate autophagy be it to increase autophagy by inhibition of DEspR-function, or to decrease autophagy by agonist stimulation of DEspR-function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biotechnology & Applied Microbiology

Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells

Victoria L. M. Herrera, Aaron H. Colby, Nelson Ruiz-Opazo, David G. Coleman, Mark W. Grinstaff

NANOMEDICINE (2018)

Article Multidisciplinary Sciences

Analysis of CD45-[CD34+/KDR+] Endothelial Progenitor Cells as Juvenile Protective Factors in a Rat Model of Ischemic-Hemorrhagic Stroke

Julius L. Decano, Ann Marie Moran, Nicholas Giordano, Nelson Ruiz-Opazo, Victoria L. M. Herrera

PLOS ONE (2013)

Article Multidisciplinary Sciences

Worse Renal Disease in Postmenopausal F2[Dahl S x R]-Intercross Rats: Detection of Novel QTLs Affecting Hypertensive Kidney Disease

Victoria L. M. Herrera, Khristine A. Pasion, Ann Marie Moran, Nelson Ruiz-Opazo

PLOS ONE (2013)

Article Multidisciplinary Sciences

Dahl (S x R) Rat Congenic Strain Analysis Confirms and Defines a Chromosome 17 Spatial Navigation Quantitative Trait Locus to <10 Mbp

Victoria L. Herrera, Khristine A. Pasion, Glaiza A. Tan, Nelson Ruiz-Opazo

PLOS ONE (2013)

Article Multidisciplinary Sciences

Sex-Specific Effects on Spatial Learning and Memory, and Sex-Independent Effects on Blood Pressure of a <3.3 Mbp Rat Chromosome 2 QTL Region in Dahl Salt-Sensitive Rats

Victoria L. Herrera, Khristine A. Pasion, Glaiza A. Tan, Ann Marie Moran, Nelson Ruiz-Opazo

PLOS ONE (2013)

Article Multidisciplinary Sciences

Multiple Susceptibility Loci for Radiation-Induced Mammary Tumorigenesis in F2[Dahl S x R]-Intercross Rats

Victoria L. Herrera, Lorenz R. Ponce, Nelson Ruiz-Opazo

PLOS ONE (2013)

Article Oncology

Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model

Christopher M. Gromisch, Glaiza L. A. Tan, Khristine Amber Pasion, Ann-Marie Moran, Matthew S. Gromisch, Mark W. Grinstaff, Francis J. Carr, Victoria L. M. Herrera, Nelson Ruiz-Opazo

Summary: This study aims to test DEspR as a therapeutic target in pancreatic peritoneal carcinomatosis (PPC) and validate hu-6g8 as a potential therapeutic. Through in vitro and in vivo experiments, the effects of DEspR inhibition on CSC functions, tumorigenesis, and overall survival were investigated.

BMC CANCER (2021)

Article Multidisciplinary Sciences

DEspRhigh neutrophils are associated with critical illness in COVID-19

Joanne T. deKay, Ivette F. Emery, Jonathan Rud, Ashley Eldridge, Christine Lord, David J. Gagnon, Teresa L. May, Victoria L. M. Herrera, Nelson Ruiz-Opazo, Richard R. Riker, Douglas B. Sawyer, Sergey Ryzhov, David B. Seder

Summary: This study investigated immune cell subpopulations in patients with COVID-19 and identified a novel subset of neutrophils associated with critical-severity COVID-19 illness, suggesting potential for targeted therapy to reduce secondary tissue damage caused by SARS-CoV-2 infection.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

A targetable 'rogue' neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS

Victoria L. M. Herrera, Allan J. Walkey, Mai Q. Nguyen, Christopher M. Gromisch, Julie Z. Mosaddhegi, Matthew S. Gromisch, Bakr Jundi, Soeren Lukassen, Saskia Carstensen, Ridiane Denis, Anna C. Belkina, Rebecca M. Baron, Mayra Pinilla-Vera, Meike Mueller, W. Taylor Kimberly, Joshua N. Goldstein, Irina Lehmann, Angela R. Shih, Roland Eils, Bruce D. Levy, Nelson Ruiz-Opazo

Summary: This study identifies DEspR+CD11b+ neutrophils as a targetable subset associated with severity and mortality in ARDS and COVID-19-ARDS. Increased peripheral DEspR+CD11b+ neutrophil counts are significantly associated with the severity and mortality in ARDS and COVID-19-ARDS. DEspR+ neutrophils and monocytes are detected in the lung tissue of ARDS and COVID-19-ARDS patients, and increased neutrophil RNA levels of DEspR ligands and modulators are found in COVID-19-ARDS scRNA-seq data files. Delayed apoptosis is observed in DEspR+CD11b+ neutrophils, and it can be blocked by hu6g8 antibody in ex vivo assays.

SCIENTIFIC REPORTS (2022)

Article Clinical Neurology

Rogue [DEspR+CD11b+] neutrophil subset correlates with severity in spontaneous intracerebral hemorrhage

Victoria L. M. Herrera, Courtney E. Takahashi, Mai Q. Nguyen, Julie Z. Mosaddeghi, Ridiane Denis, David M. Greer, Nelson Ruiz-Opazo

Summary: This study investigated the role of neutrophils in spontaneous intracerebral hemorrhage, identifying specific subsets of neutrophils associated with disease severity. The findings suggest that DEspR+CD11b+ neutrophils may serve as a potential actionable biomarker in sICH patients.

FRONTIERS IN NEUROLOGY (2022)

Article Immunology

Rogue neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury - studies in human, macaque and rat LPS-inflammation models

Saskia Carstensen, Meike Mueller, Glaiza L. A. Tan, Khristine Amber Pasion, Jens M. Hohlfeld, Victoria L. M. Herrera, Nelson Ruiz-Opazo

Summary: The correlation of DEspR+ neutrophils with severity of hypoxemia and multi-organ failure in patients with acute respiratory distress syndrome (ARDS) suggests that DEspR+ neutrophil-subset could be a therapeutic target in ARDS. In vivo studies in acute neutrophilic inflammation models confirmed the efficacy of DEspR inhibition as a potential therapeutic target for neutrophil-mediated secondary tissue injury.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

Janus USPION modular platform (JUMP) for theranostic ultrasound-mediated targeted intratumoral microvascular and DNA/miRNA

Ragnhild D. Whitaker, Julius L. Decano, Catherine Gormley, Carl A. Beigie, Cari Meisel, Glaiza A. Tan, Ann-Marie Moran, Nicholas J. Giordano, Yoonjee Park, Peng Huang, Sean Andersson, Donald Gantz, Aaron K. Grant, Nelson Ruiz-Opazo, Victoria L. M. Herrera, Joyce Y. Wong

Summary: This study reports a Janus-nanoparticle (jNP) system with multifunctional targeting, payload delivery, and targeted imaging capabilities, which shows potential breakthroughs in cancer therapy and diagnostics.

THERANOSTICS (2022)

No Data Available